On Wednesday (August 12) Kaiser Permanente Northwest announced that it has been chosen as one of three Kaiser sites in the country to participate in Pfizer’s phase three trial for a coronavirus vaccine. Kaiser Permanente will start to began clinical trials this week of a potential vaccine for COVID-19. The hospital is looking for healthy volunteers with the Kaiser system to participate in the study. For more information clickhere!
Photo: GettyImages.